Skip to Navigation
The Clatterbridge Cancer Centre NHS Foundation Trust
The Clatterbridge Cancer Centre NHS Foundation Trust incorporates The Clatterbridge Cancer Centre in Bebington, Wirral.
This trust only has results for severe acute toxicity after chemotherapy (reported 2021-22 onwards).
Other results are not relevant for this trust because it is a tertiary referral centre providing chemotherapy.
All Patients: |
Trust
|
Network
|
National
|
Number of patients in Audit |
N/A |
1582 |
35779 |
Case ascertainment (%)
|
N/A |
Good |
Good |
|
Data completeness of:
|
|
|
|
– Pre-treatment TNM (%) |
N/A |
96 |
86 |
– Performance status (%) |
N/A |
98 |
89 |
Patients having major resection: |
Trust |
Network |
National |
Number of patients in Audit |
N/A |
882 |
19631 |
ASA grade 1 (%) |
N/A |
11 |
9 |
ASA grade 2 (%) |
N/A |
56 |
53 |
ASA grade 3 (%) |
N/A |
29 |
31 |
ASA grade 4+ (%) |
N/A |
1 |
2 |
ASA grade not recorded (%) |
N/A |
3 |
4 |
|
Data completeness of: |
|
|
|
7 Audit items for risk-adjustment (%)
|
N/A |
87 |
87 |
Key:
-
- > 80%
-
- 50 - 80%
-
- < 50%
All Patients: |
Trust
|
Network
|
National
|
Number of patients in Audit |
N/A |
1582 |
35779 |
Seen by Clinical Nurse Specialist (%) |
N/A |
94 |
88 |
Patients having major resection: |
Trust
|
Network
|
National
|
Number of patients in Audit |
N/A |
882 |
19614 |
Distant metastases (%) |
N/A |
3 |
5 |
Urgent or emergency surgery (%) |
N/A |
16 |
15 |
At least 12 lymph nodes excised (%)
|
N/A |
83 |
84 |
Laparoscopic surgery attempted (%) |
N/A |
69 |
72 |
Risk-adjusted length of stay > 5 days (%)
|
N/A |
64 |
55 |
Patients having major resection for stage III colon cancer: |
Trust
|
Network
|
National
|
Number of patients in audit
|
N/A |
N/A |
10747 |
Adjuvant chemotherapy (%)
|
N/A |
N/A |
62 |
Patients receiving chemotherapy after major resection for stage III colon cancer: |
Trust
|
Network
|
National
|
Number of patients in audit
|
227 |
N/A |
6608 |
Severe acute toxicity after adjuvant chemotherapy (%)
|
23 |
N/A |
22 |
Patients having major resection: |
Trust
|
Network
|
National
|
Number of patients in Audit |
N/A |
N/A |
4251 |
Neoadjuvant therapy (%)
|
N/A |
N/A |
33 |
Circumferential resection margin: Recorded (%) |
N/A |
86 |
89 |
Circumferential resection margin: Negative (%) |
N/A |
75 |
83 |
Rectal volume
|
N/A |
N/A |
4377 |
Patients in APER/Hartmanns estimate: |
Trust
|
Network
|
National
|
Number of patients in APER/Hartmanns estimate |
N/A |
838 |
19644 |
APER/Hartmanns (%)
|
N/A |
37 |
37 |
Compare trust outcomes
Copyright © 2024 National Bowel Cancer Audit | Lovingly Crafted by
Mixd